V
主页
Addressing the challenges of cell and gene therapy manufacturing
发布人
打开封面
下载高清视频
观看高清视频
视频下载器
Utilizing the Gibco CTS Rotea System for cell and gene therapy development
Industrialization of Cell Therapy Manufacturing
Manufacturing of gene-engineered hematopoietic stem cells
High-Quality Plasmid DNA Manufacturing Strategies for Gene and Cell Therapeutics
GMP requirements for cell and gene therapy institutions
Meeting Regulatory Requirements for Cell and Gene Therapy Manufacturing
Removing analytical bottlenecks in cell therapy
Cell therapy logistics_ Exploring the last 100m
Stem Cell Therapie's Potential in the Pandemic Era
Simplifying GMP CAR T and CAR NK cell therapy manufacturing processes
2022 WMIF,The Cell Therapy Landscape,CAR-T to Stem Cells
Understanding & predicting outcomes in CAR T-cell therapy
2022 WMIF,Cell Therapy and Transplantation for Parkinson'sease
Off-the-shelf NK cell therapy [WEBINAR]
How cell and gene therapies can transform the treatment of solid tumours
CAR-T Cell Therapy_ Now and in 2030
GMP Raw Materials for Cell Therapy - What, When, How?
A cGMP Compatible, Non-Viral CAR T Cell Manufacturing Process
All you need for T cell research
Lentivirus vector manufacturing using suspension cell line
CAR-T Generation for Identity, Purity and Potency Assay Testing
A CRISPR Vision for the Future of Cell Therapy
Keynote_ Carl June | Therapy Gladstone-UCSF
Blocking ADAM17 as a therapeutic approach to increase human NK cell proliferatio
High Cell Density and Perfusion Process Solutions
温度分布验证相关考虑
计算机化系统GMP要求
生物制药的GMP检查要求
Engineering iPSC-derived Natural Killer Cells
CFDI《细胞质量产品GMP指南》解读
Megakaryopoiesis
洁净室物品GMP管理要求
实验室记录与数据管理
Dr. Carl June Presenting at Nobel Conference
GMP物料管理系统
细胞库GMP管理要求
稳定性试验的条件和具体实施要点和要求
消毒技术
QA人员现场管理
Intro to Good Manufacturing Practice